Sao Paulo / Frankfurt:
Brazilian health authority Avisa said on Wednesday that a volunteer had died in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and the University of Oxford, but also said the trial would continue.
Oxford confirmed its intention to organize the test, saying in a statement that after careful evaluation “there have been no concerns about the safety of the clinical trial”.
AstraZeneca immediately declined to comment.
A source familiar with the matter told Reuters the trial would have been put on hold had Troweller died, receiving the COVID-19 vaccine, suggesting the individual was in the control group. Received the meningitis vaccine.
The Federal University of São Paulo, which helps coordinate phase 3 clinical trials in Brazil, said an independent review panel had also recommended that the trial continue. The university previously confirmed that the volunteer was from Brazil, but did not provide any other personal details.
The University of Brazil said in a statement: “Everything is going according to plan without any involvement of the participating volunteers who are seriously concerned about the vaccination.”
The university spokesperson said 8,000 of the 10,000 volunteers employed in the trial had been recruited and were receiving the first dose in six Brazilian cities.
CNN Brasil reported that the volunteer was a 28-year-old man who lived in Rio de Janeiro and had died of complications from COVID-19.
Avisa did not provide any additional details, citing the medical confidentiality of those involved in the trials.
AstraZeneca stock fell 1.8%.
The Brazilian federal government plans to purchase the British vaccine and produce it at the FioCruz Biomedical Research Center in Rio de Janeiro, while a competing vaccine from Chinese company Synovac Biotech Ltd has been tested by the Butanoan Institute of Research in the ‘State of São Paulo. Going.
Brazilian President Jair Bolonaro said on Wednesday that the federal government would not buy the Synovac vaccine.
Brazil has the second deadliest coronovirus outbreak, after the United States, killing more than 154,000 people. It is the third highest number, after the United States and India, with more than 5.2 million people infected.